Understanding monogenic Parkinson’s disease at a global scale
View ORCID ProfileJohanna Junker, View ORCID ProfileLara M. Lange, View ORCID ProfileEva-Juliane Vollstedt, View ORCID ProfileKarisha Roopnarain, View ORCID ProfileMaria Leila M. Doquenia, View ORCID ProfileAzlina Ahmad Annuar, View ORCID ProfileMicol Avenali, View ORCID ProfileSoraya Bardien, View ORCID ProfileNatascha Bahr, View ORCID ProfileMelina Ellis, View ORCID ProfileCaterina Galandra, View ORCID ProfileThomas Gasser, View ORCID ProfilePeter Heutink, View ORCID ProfileAnastasia Illarionova, View ORCID ProfileYuliia Kanana, View ORCID ProfileIgnacio J. Keller Sarmiento, View ORCID ProfileKishore R. Kumar, View ORCID ProfileShen-Yang Lim, View ORCID ProfileHarutyun Madoev, View ORCID ProfileIgnacio F. Mata, View ORCID ProfileNiccolò E. Mencacci, Mike A. Nalls, Shalini Padmanabhan, View ORCID ProfileCholpon Shambetova, View ORCID ProfileJ Solle, View ORCID ProfileAi-Huey Tan, View ORCID ProfileJoanne Trinh, View ORCID ProfileEnza Maria Valente, Andrew Singleton, View ORCID ProfileCornelis Blauwendraat, View ORCID ProfileKatja Lohmann, View ORCID ProfileZih-Hua Fang, View ORCID ProfileChristine Klein, the Global Parkinson’s Genetics Program (GP2)
doi: https://doi.org/10.1101/2024.03.12.24304154
Johanna Junker
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
2Department of Neurology, University Clinic Schleswig-Holstein, Luebeck, Germany
MDLara M. Lange
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
2Department of Neurology, University Clinic Schleswig-Holstein, Luebeck, Germany
MDEva-Juliane Vollstedt
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
MDKarisha Roopnarain
3Department of Neurology, University of Free State, Bloemfontein, South Africa
MDMaria Leila M. Doquenia
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
MDAzlina Ahmad Annuar
4Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
PhDMicol Avenali
5Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
6IRCCS Mondino Foundation, Pavia, Italy
MDSoraya Bardien
7Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
8South African Medical Research Council, Genomics of Brain Disorders Research Unit, Stellenbosch University, Cape Town, South Africa
PhDNatascha Bahr
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
Melina Ellis
9Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, New South Wales, Australia
10Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
BScCaterina Galandra
5Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
11Department of Molecular Medicine, University of Pavia, Pavia, Italy
MDThomas Gasser
12Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
13German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
MD, FANA, FEANPeter Heutink
12Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
13German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
PhDAnastasia Illarionova
13German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
PhDYuliia Kanana
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
PhDIgnacio J. Keller Sarmiento
14Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
MDKishore R. Kumar
10Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
15Translational Neurogenomics, Genomic and Inherited Disease Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
16Molecular Medicine Laboratory and Neurology Department, Concord Repatriation General Hospital, The University of Sydney, Concord, New South Wales, Australia
MBBS, PhD, FRACPShen-Yang Lim
17Division of Neurology, Department of Medicine, and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson’s and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
MD, FRACPHarutyun Madoev
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
MSIgnacio F. Mata
18Genomic Medicine Institute (GMI), Cleveland Clinic, Cleveland, OH, United States
PhDNiccolò E. Mencacci
14Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA
MD, PhDMike A. Nalls
19DataTecnica, Washington DC, USA
20Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
PhDShalini Padmanabhan
21Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson’s Research, New York, New York, USA
PhDCholpon Shambetova
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
MDJ Solle
22Department of Clinical Research, Michael J. Fox Foundation for Parkinson’s Research, New York City, NY, USA
MBAAi-Huey Tan
17Division of Neurology, Department of Medicine, and the Mah Pooi Soo and Tan Chin Nam Centre for Parkinson’s and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
MD, PhD, FRCPJoanne Trinh
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
PhDEnza Maria Valente
6IRCCS Mondino Foundation, Pavia, Italy
11Department of Molecular Medicine, University of Pavia, Pavia, Italy
MDAndrew Singleton
20Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
23Laboratory of Neurogenetics, National Institute on Aging, National Institutes ofHealth, Bethesda, MD, USA
PhDCornelis Blauwendraat
20Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
PhDKatja Lohmann
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
PhDZih-Hua Fang
13German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
PhDChristine Klein
1Institute of Neurogenetics, University of Luebeck, Luebeck, Germany
MDData Availability
Anonymized data are available upon reasonable request from any qualified investigator to the authors.
Posted April 09, 2024.
Understanding monogenic Parkinson’s disease at a global scale
Johanna Junker, Lara M. Lange, Eva-Juliane Vollstedt, Karisha Roopnarain, Maria Leila M. Doquenia, Azlina Ahmad Annuar, Micol Avenali, Soraya Bardien, Natascha Bahr, Melina Ellis, Caterina Galandra, Thomas Gasser, Peter Heutink, Anastasia Illarionova, Yuliia Kanana, Ignacio J. Keller Sarmiento, Kishore R. Kumar, Shen-Yang Lim, Harutyun Madoev, Ignacio F. Mata, Niccolò E. Mencacci, Mike A. Nalls, Shalini Padmanabhan, Cholpon Shambetova, J Solle, Ai-Huey Tan, Joanne Trinh, Enza Maria Valente, Andrew Singleton, Cornelis Blauwendraat, Katja Lohmann, Zih-Hua Fang, Christine Klein, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2024.03.12.24304154; doi: https://doi.org/10.1101/2024.03.12.24304154
Understanding monogenic Parkinson’s disease at a global scale
Johanna Junker, Lara M. Lange, Eva-Juliane Vollstedt, Karisha Roopnarain, Maria Leila M. Doquenia, Azlina Ahmad Annuar, Micol Avenali, Soraya Bardien, Natascha Bahr, Melina Ellis, Caterina Galandra, Thomas Gasser, Peter Heutink, Anastasia Illarionova, Yuliia Kanana, Ignacio J. Keller Sarmiento, Kishore R. Kumar, Shen-Yang Lim, Harutyun Madoev, Ignacio F. Mata, Niccolò E. Mencacci, Mike A. Nalls, Shalini Padmanabhan, Cholpon Shambetova, J Solle, Ai-Huey Tan, Joanne Trinh, Enza Maria Valente, Andrew Singleton, Cornelis Blauwendraat, Katja Lohmann, Zih-Hua Fang, Christine Klein, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2024.03.12.24304154; doi: https://doi.org/10.1101/2024.03.12.24304154
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2966)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12789)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4613)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2940)
- Health Policy (1071)
- Hematology (393)
- HIV/AIDS (929)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4394)
- Nursing (237)
- Nutrition (646)
- Oncology (2286)
- Ophthalmology (651)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (502)
- Public and Global Health (6986)
- Radiology and Imaging (1540)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)